Structurally Engineered Ferrous Metal–Organic Framework as a Chemodynamic Therapy Nanoagent for Concurrent Hydroxyl Radical and Singlet Oxygen Generation
Advanced Functional Materials · 2026-04 · 36 (35)
DOI: 10.1002/adfm.202529194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 26.01.2026. Verfasst von Chao Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, 2730 SW Moody Avenue, Portland, Oregon, 97201, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Chemodynamic therapy (CDT) is an emerging cancer treatment that employs transition metal–based nanoagents to catalyze the conversion of elevated intracellular hydrogen peroxide in malignant cells into cytotoxic hydroxyl radicals (•OH) via Fenton‐like reactions. Recent developments have also introduced CDT agents that generate singlet oxygen ( 1 O 2 ) through the Russell mechanism. However, current nanoplatforms efficiently produce either •OH or 1 O 2 , but not both, and often exhibit suboptimal catalytic activity, thereby limiting the sufficient production of reactive oxygen species (ROS) required for cancer eradication. This report introduces a ferrous metal–organic framework, Fe(II)‐TCPP (tetrakis(4‐carboxyphenyl)porphyrin), as the first nanoagent capable of simultaneously and effectively generating •OH and 1 O 2 through dual catalytic pathways. Its nanoneedle‐like morphology increases the surface area and promotes enhanced ROS production. Cell studies demonstrated selective intracellular generation of •OH and 1 O 2 in cancer cells, resulting in targeted cytotoxicity while sparing non‐malignant cells. Systemic administration of Fe(II)‐TCPP in a breast cancer mouse model resulted in preferential tumor accumulation, robust intratumoral ROS generation, cancer eradication, and prevention of recurrence without systemic toxicity. These findings mark a foundational advance in CDT nanoagents by integrating Fenton and Russell mechanisms into a single platform, enabling the design of multifunctional catalysts with enhanced ROS output and therapeutic efficacy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, 2730 SW Moody Avenue, Portland, Oregon, 97201, USA.
Förderung
- NCI NIH HHS
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Wang, C., Sharma, K. S., Goo, Y. T., Grigoriev, V., Raitmayr, C., Mesquita Souza, A. P., Phawde, M. P., Taratula, O. R., & Taratula, O. (2026). Structurally Engineered Ferrous Metal–Organic Framework as a Chemodynamic Therapy Nanoagent for Concurrent Hydroxyl Radical and Singlet Oxygen Generation. Advanced Functional Materials, 36(35). https://doi.org/10.1002/adfm.202529194
Vancouver
Wang C, Sharma KS, Goo YT, Grigoriev V, Raitmayr C, Mesquita Souza AP, et al. Structurally Engineered Ferrous Metal–Organic Framework as a Chemodynamic Therapy Nanoagent for Concurrent Hydroxyl Radical and Singlet Oxygen Generation. Advanced Functional Materials. 2026;36(35). doi:10.1002/adfm.202529194
BibTeX
@article{Wang2026,
author = {Wang, Chao and Sharma, Kongbrailatpam Shitaljit and Goo, Yoon Tae and Grigoriev, Vladislav and Raitmayr, Constanze and Mesquita Souza, Ana Paula and Phawde, Manali Parag and Taratula, Olena R and Taratula, Oleh},
title = {Structurally Engineered Ferrous Metal–Organic Framework as a Chemodynamic Therapy Nanoagent for Concurrent Hydroxyl Radical and Singlet Oxygen Generation},
journal = {Advanced Functional Materials},
year = {2026},
volume = {36},
number = {35},
doi = {10.1002/adfm.202529194}
}
EUVIMED